A Study of K-645 in the Treatment of Multiple Migraine Attacks

NCT07116499 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

134

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped for futility based on an interim analysis of efficacy.

Conditions

Acute Migraine

Interventions

DRUG: Placebo
DRUG: K-645 dose level 1
DRUG: K-645 dose level 2

Sponsor

Kallyope Inc.